DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Issue 11 · Volume 19 · November 1987 DOI: 10.1055/s-002-8242

REVIEW

519
Bettendorf, G.; Lindner, Ch.: The Ovarian Hyperstimulation Syndrome

ORIGINALS

Basic

523
Hoet, J. J.; Reusens, B.; Remacle, Cl: Lessons from the Pathology of the Diabetic Pancreas
526
Leclerq-Meyer, V.; Giroix, M.-H.; Sener, A.; Marchand, J.; Malaisse, W. J.: 32P, 86Rb+ and 45Ca2+ Handling by Tumoral Insulin-Secreting Cells (RINm5F Line)
534
Zhao, Z.-H.; Watschinger, B.; Brown, C. D.; Beyer, Monica M.; Friedman, E. A.: Variations of Susceptibility to Alloxan Induced Diabetes in the Rabbit
545
Foglia, V. G.; Heller, C. L.; Becú-Villalobos, D.; Weisenberg, L. S.; Lacau de Mengido, I. M.; Piroli, G.; Libertun, C.; De Nicola, A. F.: Neuroendocrine Changes in Female Rats Born from Streptozotocin-Diabetic Mothers
549
Casulari, L. A.; Maggi, R.; Dondi, D.; Limonta, P.; Piva, F.; Motta, M.; Martini, L.: Effect of Oestrus Cyclicity on the Number of Brain Opioid Mu Receptors in the Rat

Clinical

569
Diamantopoulos, E. J.; Raptis, S. A.; Moulopoulos, S. D.: Red Blood Cell Deformability Index in Diabetic Retinopathy
574
Hadjidakis, D. I.; Raptis, S. A.; Raptis, A. E.; Karaiskos, C.; Souvatzoglou, A.; Diamantopoulos, E. J.: The Antidiabetic Action of Somatostatin-28 as Assessed by the Artificial Endocrine Pancreas: Greater Potency than Somatostatin-14
585
Nicholson, G. C.; Horton, M. A.; Sexton, P. M.; D'Santos, C. S.; Moseley, J. M.; Kemp, B. E.; Pringle, J. A. S.; Martin, T. J.: Calcitonin Receptors of Human Osteoclastoma